Placental Vascular and Inflammatory Findings from Pregnancies Diagnosed with Coronavirus Disease 2019: A Systematic Review and Meta-analysis

Abstract

We aimed to perform a meta-analysis of the literature concerning histopathologic findings in the placentas of women with SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection during pregnancy. Searches for articles in English included PubMed, Web of Science, Google Scholar, and reference lists (up to April 2021). Studies presenting data on placental histopathology according to the Amsterdam Consensus Group criteria in SARS-CoV-2 positive and negative pregnancies were identified. Lesions were categorized into: maternal and fetal vascular malperfusion (MVM and FVM, respectively), acute placental inflammation with maternal and fetal inflammatory response (MIR and FIR, respectively), chronic inflammatory lesions (CILs), and increased perivillous fibrin deposition (PVFD). A total of 15 studies reporting on 19,025 placentas, n = 699 of which were derived from women who were identified as being infected with SARS-CoV-2 and 18,326 as SARS-CoV-2-negative controls, were eligible for analysis. No significant difference in incidence of MVM (odds ratio [OR]: 1.18, 95% confidence interval [CI]: 0.73–1.90), FVM (OR: 1.23, 95% CI: 0.63–2.42), MIR (OR: 0.66, 95% CI: 0.29–1.52) or FIR (OR: 0.85, 95% CI: 0.44–1.63), and CILs (OR: 0.97, 95% CI: 0.55–1.72) was found between placentae from gravida identified as being SARS-CoV-2 infected. However, placenta from gravida identified as being infected with SARS-CoV-2 were associated with significantly increased occurrence of PVFD (OR: 2.77, 95% CI: 1.06–7.27). After subgroup analyses based on clinical severity of COVID-19 infection, no significant difference was observed in terms of reported placental pathology between symptomatic or asymptomatic SARS-CoV-2 gravidae placenta. Current evidence based on the available literature suggests that the only pathologic finding in the placentae of women who are pregnant identified as having been infected with SARS-CoV-2 was an increased prevalence of PVFD.

Key Points

• No association between SARS-CoV-2 and maternal or fetal placental malperfusion.

• No association between SARS-CoV-2 and maternal or fetal inflammatory response.

• SARS-CoV-2 is associated with increased perivillous fibrin deposition in placenta.

Keywords

COVID-19 - SARS-CoV-2 - placenta - pregnancy - pathology - meta-analysis

Data Availability Statement

The data that support the findings of this study are available on request from the corresponding author ([e-mail]; [e-mail]).

Authors' Contributions

K.H. and A.A.S. conceived and designed the study; K.H., E.R.B., M.D.S., and A.A.N. collected the data; K.H. performed the analysis; K.H., K.M.A., and S.E.A. wrote the paper; E.C.C. performed pathological assessment. All authors read the final version and manuscript and approved it for the submission.

Registration

This systematic review and meta-analysis was prospectively PROSPERO (CRD42021251458).

Publikationsverlauf

Eingereicht: 12. November 2021

Angenommen: 18. Februar 2022

Accepted Manuscript online:
03. März 2022

Artikel online veröffentlicht:
31. Mai 2022

• References

• 1 Rasmussen SA, Jamieson DJ, Uyeki TM. Effects of influenza on pregnant women and infants. Am J Obstet Gynecol 2012; 207 (3, Suppl): S3-S8
• 2 Aagaard-Tillery K, Silver R, Dalton J. Immunology of normal pregnancy. Semin Fetal Neonatal Med 2006; 11: 279-295
• 3 Littauer EQ, Skountzou I. Hormonal regulation of physiology, innate immunity and antibody response to H1N1 influenza virus infection during pregnancy. Front Immunol 2018; 9: 2455
• 4 Mosby LG, Rasmussen SA, Jamieson DJ. 2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature. Am J Obstet Gynecol 2011; 205 (01) 10-18
• 5 Ellington S, Strid P, Tong VT. et al. Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status—United States, January 22–June 7, 2020. MMWR Morb Mortal Wkly Rep 2020; 69 (25) 769-775
• 6 Wong SF, Chow KM, Leung TN. et al. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol 2004; 191 (01) 292-297
• 7 Connors JM, Levy JH. COVID-19 and its implications for thrombosis and anticoagulation. Blood 2020; 135 (23) 2033-2040
• 8 Patberg ET, Adams T, Rekawek P. et al. Coronavirus disease 2019 infection and placental histopathology in women delivering at term. Am J Obstet Gynecol 2021; 224 (04) 382.e1-382.e18
• 9 Zhang P, Heyman T, Greechan M. et al. Maternal, neonatal and placental characteristics of SARS-CoV-2 positive mothers. J Matern Fetal Neonatal Med 2021; •••: 1-9
• 10 Seferovic MD, Turley M, Valentine GC. et al. Clinical importance of placental testing among suspected cases of congenital Zika syndrome. Int J Mol Sci 2019; 20 (03) E712
• 11 Seferovic M, Sánchez-San Martín C, Tardif SD. et al. Experimental Zika virus infection in the pregnant common marmoset induces spontaneous fetal loss and neurodevelopmental abnormalities. Sci Rep 2018; 8 (01) 6851
• 12 de Noronha L, Zanluca C, Burger M. et al. Zika virus infection at different pregnancy stages: anatomopathological findings, target cells and viral persistence in placental tissues. Front Microbiol 2018; 9: 2266
• 13 Schwartz DA. Viral infection, proliferation, and hyperplasia of Hofbauer cells and absence of inflammation characterize the placental pathology of fetuses with congenital Zika virus infection. Arch Gynecol Obstet 2017; 295 (06) 1361-1368
• 14 Hirsch AJ, Roberts VHJ, Grigsby PL. et al. Zika virus infection in pregnant rhesus macaques causes placental dysfunction and immunopathology. Nat Commun 2018; 9 (01) 263
• 15 Taglauer E, Benarroch Y, Rop K. et al. Consistent localization of SARS-CoV-2 spike glycoprotein and ACE2 over TMPRSS2 predominance in placental villi of 15 COVID-19 positive maternal-fetal dyads. Placenta 2020; 100: 69-74
• 16 Ouyang Y, Bagalkot T, Fitzgerald W. et al. Term human placental trophoblasts express SARS-CoV-2 entry factors ACE2, TMPRSS2, and furin. MSphere 2021; 6 (02) e00250-21
• 17 Tallarek A-C, Urbschat C, Fonseca Brito L. et al. Inefficient placental virus replication and absence of neonatal cell-specific immunity upon Sars-CoV-2 infection during pregnancy. Front Immunol 2021; 12 (2047): 698578
• 18 Khong TY, Mooney EE, Ariel I. et al. Sampling and definitions of placental lesions: Amsterdam Placental Workshop Group consensus statement. Arch Pathol Lab Med 2016; 140 (07) 698-713
• 19 Goldstein JA, Gallagher K, Beck C, Kumar R, Gernand AD. Maternal-fetal inflammation in the placenta and the developmental origins of health and disease. Front Immunol 2020; 11 (2786): 531543
• 20 Kim CJ, Romero R, Chaemsaithong P, Chaiyasit N, Yoon BH, Kim YM. Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance. Am J Obstet Gynecol 2015; 213 (4, Suppl): S29-S52
• 21 von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg 2014; 12 (12) 1495-1499
• 22 Rahmani N, Salehi A, Molavi Vardanjani H, Marzban M, Behbood A. Using STROBE checklist to assess the reporting quality of observational studies affiliated with Shiraz University of Medical Sciences, and its correlates: a scientometric study from Iran. Scientometrics 2020; 122 (02) 989-1001
• 23 Debelenko L, Katsyv I, Chong AM, Peruyero L, Szabolcs M, Uhlemann AC. Trophoblast damage with acute and chronic intervillositis: disruption of the placental barrier by severe acute respiratory syndrome coronavirus 2. Hum Pathol 2021; 109: 69-79
• 24 Edlow AG, Li JZ, Collier AY. et al. Assessment of maternal and neonatal SARS-CoV-2 viral load, transplacental antibody transfer, and placental pathology in pregnancies during the COVID-19 pandemic. JAMA Netw Open 2020; 3 (12) e2030455
• 25 Gulersen M, Prasannan L, Tam Tam H. et al. Histopathologic evaluation of placentas after diagnosis of maternal severe acute respiratory syndrome coronavirus 2 infection. Am J Obstet Gynecol MFM 2020; 2 (04) 100211
• 26 He M, Skaria P, Kreutz K, Chen L, Hagemann IS, Carter EB, Mysorekar IU, Nelson DM, Pfeifer J, Dehner LP. Histopathology of Third Trimester Placenta from SARS-CoV-2-Positive Women. Fetal Pediatr Pathol 2020; Oct 12: 1-10
• 27 Levitan D, London V, McLaren RA. et al. Histologic and immunohistochemical evaluation of 65 placentas from women with polymerase chain reaction-proven severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Arch Pathol Lab Med 2021; 145 (06) 648-656
• 28 Shanes ED, Mithal LB, Otero S, Azad HA, Miller ES, Goldstein JA. Placental pathology in COVID-19. Am J Clin Pathol 2020; 154 (01) 23-32
• 29 Lu-Culligan A, Chavan AR, Vijayakumar P, Irshaid L, Courchaine EM, Milano KM, Tang Z, Pope SD, Song E, Vogels CB, Lu-Culligan WJ. Maternal respiratory SARS-CoV-2 infection in pregnancy is associated with a robust inflammatory response at the maternal-fetal interface. Med. 2021; May 14 2 (05) 591-610
• 30 Blasco Santana L, Miraval Wong E, Álvarez-Troncoso J, Sánchez García L, Bartha JL, Regojo-Zapata RM. Maternal and perinatal outcomes and placental pathologic examination of 29 SARS-CoV-2 infected patients in the third trimester of gestation. J Obstet Gynaecol Res 2021; 47 (06) 2131-2139
• 31 Resta L, Vimercati A, Cazzato G. et al. SARS-CoV-2 and placenta: new insights and perspectives. Viruses 2021; 13 (05) 723
• 32 Tasca C, Rossi RS, Corti S. et al. Placental pathology in COVID-19 affected pregnant women: a prospective case-control study. Placenta 2021; 110: 9-15
• 33 Bertero L, Borella F, Botta G. et al. Placenta histopathology in SARS-CoV-2 infection: analysis of a consecutive series and comparison with control cohorts. Virchows Arch 2021; 479 (04) 715-728
• 34 Rebutini PZ, Zanchettin AC, Stonoga ETS. et al. Association between COVID-19 pregnant women symptoms severity and placental morphologic features. Front Immunol 2021; 12: 685919
• 35 Jaiswal N, Puri M, Agarwal K. et al. COVID-19 as an independent risk factor for subclinical placental dysfunction. Eur J Obstet Gynecol Reprod Biol 2021; 259: 7-11
• 36 Sharps MC, Hayes DJL, Lee S. et al. A structured review of placental morphology and histopathological lesions associated with SARS-CoV-2 infection. Placenta 2020; 101: 13-29
• 37 Di Girolamo R, Khalil A, Alameddine S. et al. Placental histopathology after SARS-CoV-2 infection in pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol MFM 2021; 3 (06) 100468
• 38 Gadanec LK, McSweeney KR, Qaradakhi T, Ali B, Zulli A, Apostolopoulos V. Can SARS-CoV-2 virus use multiple receptors to enter host cells?. Int J Mol Sci 2021; 22 (03) 992
• 39 Li M, Chen L, Zhang J, Xiong C, Li X. The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study. PLoS One 2020; 15 (04) e0230295
• 40 Singh M, Bansal V, Feschotte C. A single-cell RNA expression map of human coronavirus entry factors. Cell Rep 2020; 32 (12) 108175
• 41 Ashary N, Bhide A, Chakraborty P. et al. Single-cell RNA-seq identifies cell subsets in human placenta that highly expresses factors driving pathogenesis of SARS-CoV-2. Front Cell Dev Biol 2020; 8: 783
• 42 Cui D, Liu Y, Jiang X. et al. Single-cell RNA expression profiling of SARS-CoV-2-related ACE2 and TMPRSS2 in human trophectoderm and placenta. Ultrasound Obstet Gynecol 2021; 57 (02) 248-256
• 43 Zheng Q-L, Duan T, Jin L-P. Single-cell RNA expression profiling of ACE2 and AXL in the human maternal–fetal interface. Reprod Dev Med 2020; 4 (01) 7-10
• 44 Faure-Bardon V, Isnard P, Roux N. et al. Protein expression of angiotensin-converting enzyme 2, a SARS-CoV-2-specific receptor, in fetal and placental tissues throughout gestation: new insight for perinatal counseling. Ultrasound Obstet Gynecol 2021; 57 (02) 242-247
• 45 Pique-Regi R, Romero R, Tarca AL. et al. Does the human placenta express the canonical cell entry mediators for SARS-CoV-2?. eLife 2020; 9: e58716
• 46 Malinowski AK, Noureldin A, Othman M. COVID-19 susceptibility in pregnancy: Immune/inflammatory considerations, the role of placental ACE-2 and research considerations. Reprod Biol 2020; 20 (04) 568-572
• 47 Blair RV, Vaccari M, Doyle-Meyers LA. et al. Acute respiratory distress in aged, SARS-CoV-2-infected african green monkeys but not rhesus macaques. Am J Pathol 2021; 191 (02) 274-282
• 48 Körner RW, Majjouti M, Alcazar MAA, Mahabir E. Of mice and men: the coronavirus MHV and mouse models as a translational approach to understand SARS-CoV-2. Viruses 2020; 12 (08) 880